Random Opioid Testing Required For Pilots, Train Engineers, DOT Announces

In response to the worsening opioid abuse and overdose epidemic in the United States, federal regulators have issued a new rule that requires random drug testing that looks for opioid use among transportation workers engaged in safety-sensitive jobs, such as truck drivers, pilots and train engineers. 

The Department of Transportation (DOT) issued a final ruling (PDF) on the new drug tests for transportation workers this week, which will be published in the Federal Register on November 13. The rules require random drug tests for transportation workers to include narcotic painkillers, like Norco, Vicodin, and OxyContin.

The ruling will take effect January 1, applying to airline pilots, train engineers, and truck drivers who are subject to federally mandated drug screenings.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The change comes amid increasing concerns over the opioid abuse and overdose epidemic in the United States. A recent study indicated the number of opioid-related deaths may be much higher than officials estimate and the number of overdose deaths have increased, despite less people abusing opioids.

Currently, transportation workers are subject to random drug screenings; however, the drug screenings only test for marijuana, cocaine, PCP, and heroin.

The new ruling calls for drug screenings for any safety-sensitive transportation workers to also include testing for opioid drugs, including hydrocodone, hydromorphone, oxymorphone and oxycodone.

The announcement noted that DOT received 52 comments from the public and interest groups on the new rule, which will bring testing in line with certain requirements by the Department of Health and Human Services (HHS). Of those, 41 were in support of the new testing requirements.

“Supporters generally recognized the need for the Department to act consistently with the HHS Mandatory Guidelines and agreed that addressing opioid abuse issues in the context of transportation safety is important,” the federal register notice states. “Of the other 11 comments, several expressed concerns that adding these substances would increase circumstances in which drivers innocently using opioids (e.g., via a prescription 8 for pain medication) would be unfairly treated as drug abusers, with consequent positive tests harming their careers.”

Last year, two Amtrak workers who were struck and killed by an Amtrak train tested positive for oxycodone and cocaine. The oxycodone was only detected because drug tests done after accidents screen for more substances than random routine drug tests conducted on employees.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted today)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted yesterday)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).